Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1986 3
1987 3
1989 3
1990 2
1991 4
1992 4
1993 6
1994 11
1995 7
1996 9
1997 12
1998 7
1999 7
2000 11
2001 10
2002 11
2003 8
2004 8
2005 8
2006 14
2007 14
2008 11
2009 7
2010 14
2011 18
2012 14
2013 12
2014 16
2015 15
2016 13
2017 20
2018 10
2019 9
2020 14
2021 8
2022 12
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

330 results
Results by year
Filters applied: . Clear all
Page 1
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.
Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C, Hilton Boon M, Kantar A, Lai K, McGarvey L, Rigau D, Satia I, Smith J, Song WJ, Tonia T, van den Berg JWK, van Manen MJG, Zacharasiewicz A. Morice AH, et al. Eur Respir J. 2020 Jan 2;55(1):1901136. doi: 10.1183/13993003.01136-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 31515408 Free PMC article.
Drug-Induced Cough.
Shim JS, Song WJ, Morice AH. Shim JS, et al. Among authors: morice ah. Physiol Res. 2020 Mar 27;69(Suppl 1):S81-S92. doi: 10.33549/physiolres.934406. Physiol Res. 2020. PMID: 32228014 Free PMC article. Review.
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
McGarvey LP, Birring SS, Morice AH, Dicpinigaitis PV, Pavord ID, Schelfhout J, Nguyen AM, Li Q, Tzontcheva A, Iskold B, Green SA, Rosa C, Muccino DR, Smith JA; COUGH-1 and COUGH-2 Investigators. McGarvey LP, et al. Among authors: morice ah. Lancet. 2022 Mar 5;399(10328):909-923. doi: 10.1016/S0140-6736(21)02348-5. Lancet. 2022. PMID: 35248186 Clinical Trial.
Combating cough.
Morice AH. Morice AH. NPJ Prim Care Respir Med. 2016 Mar 3;26:16012. doi: 10.1038/npjpcrm.2016.12. NPJ Prim Care Respir Med. 2016. PMID: 26937873 Free PMC article. No abstract available.
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial.
Smith JA, Kitt MM, Morice AH, Birring SS, McGarvey LP, Sher MR, Li YP, Wu WC, Xu ZJ, Muccino DR, Ford AP; Protocol 012 Investigators. Smith JA, et al. Among authors: morice ah. Lancet Respir Med. 2020 Aug;8(8):775-785. doi: 10.1016/S2213-2600(19)30471-0. Epub 2020 Feb 25. Lancet Respir Med. 2020. PMID: 32109425 Clinical Trial.
COVID-19 controversy: when to intubate?
Morice AH. Morice AH. ERJ Open Res. 2021 Apr 6;7(2):00185-2021. doi: 10.1183/23120541.00185-2021. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 33834050 Free PMC article.
Understanding cough.
Morice AH, Widdicombe J, Dicpinigaitis P, Groenke L. Morice AH, et al. Eur Respir J. 2002 Jan;19(1):6-7. doi: 10.1183/09031936.02.00281002. Eur Respir J. 2002. PMID: 11843328 Free article. No abstract available.
Airway disease: a confusion inside an enigma.
Morice AH. Morice AH. ERJ Open Res. 2022 Dec 12;8(4):00519-2022. doi: 10.1183/23120541.00519-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36655221 Free PMC article.
330 results